MSK patient and acclaimed jazz pianist Michael Wolff (far right) celebrates surviving a rare cancer surrounded by his family (left to right): sons Nat and Alex Wolff and wife Polly Draper. MSK ...

Memorial Sloan Kettering Cancer Center researchers continued to make strides against cancer in 2025. Learn about some of their top discoveries.

Members of the team that developed MSK-ACCESS. From left to right: Michael Berger, Marc Ladanyi, Dana Tsui, Rose Brannon, Ryma Benayed, Ahmet Zehir, and David Klimstra. Photo from February 2020. One ...

Champion Health System leads the way in non-surgical joint pain treatments with groundbreaking procedures like Genicular ...

Memorial Sloan Kettering Cancer Center and health insurer Anthem Blue Cross and Blue Shield have reached a deal on payment rates, maintaining coverage of cancer services for thousands of patients in ...

More than 1,600 Blue Shield of California members have registered for a musculoskeletal (MSK) program through the payer's digital health platform since its launch in January. The Wellvolution platform ...

A new study, State of MSK Report, which sources its data from the CDC as well as the National Health Interview Survey (NHIS), representing over 252 million American adults, produced some rather ...

Sometimes investing gets personal. When I started looking at virtual, digital healthcare platforms for musculoskeletal conditions, it hit close to the bone, specifically the knees. I shot mine hanging ...

One in two Americans lives with pain from a musculoskeletal (MSK) disorder, and these conditions have become a leading driver of employer health costs as their workers seek relief with a variety of ...

Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...